First trimester serum markers stability during sample transportation from the obstetrical site to the screening laboratory

References

• Nicolaides KH. First-trimester screening for chromosomal abnormalities. Semin Perinatol 2005;29:190–194.
   PubMed Web of Science ®Google Scholar
• Leung TY, Chan LW, Leung TN, Fung TY, Sahota DS, Spencer K, Lau TK. First-trimester combined screening for trisomy 21 in a predominantly Chinese population. Ultrasound Obstet Gynecol 2007;29:14–17.
   PubMed Web of Science ®Google Scholar
• Leung TY, Chan LW, Law LW, Sahota DS, Fung TY, Leung TN, Lau TK. First trimester combined screening for Trisomy 21 in Hong Kong: outcome of the first 10,000 cases. J Matern Fetal Neonatal Med 2009;22:300–304.
   PubMed Web of Science ®Google Scholar
• Lambert-Messerlian GM, Eklund EE, Malone FD, Palomaki GE, Canick JA, D’Alton ME. Stability of first- and second-trimester serum markers after storage and shipment. Prenat Diagn 2006;26:17–21.
   PubMed Web of Science ®Google Scholar
• Knight GJ, Cole LA. Measurement of choriogonadotropin free beta-subunit: an alternative to choriogonadotropin in screening for fetal Down’s syndrome? Clin Chem 1991;37:779–782.
   PubMed Web of Science ®Google Scholar
• Spencer K, Macri JN, Carpenter P, Anderson R, Krantz DA. Stability of intact chorionic gonadotropin (hCG) in serum, liquid whole blood, and dried whole-blood filter-paper spots: impact on screening for Down syndrome by measurement of free beta-hCG subunit. Clin Chem 1993;39:1064–1068.
   PubMed Web of Science ®Google Scholar
• Zimmermann R, Keller PJ, Huch A. Increased maternal serum free beta-human chorionic gonadotrophin concentrations in Down’s pregnancies: an artefactual finding? Br J Obstet Gynaecol 1994;101:257–258.
   PubMedGoogle Scholar
• Cuckle HS, Jones RG. Maternal serum-free beta-human chorionic gonadotrophin level: the effect of sample transportation. Ann Clin Biochem 1994;31 (Pt 1):97–98.
   PubMedGoogle Scholar
• Lantz ME, O’Brien WF, Williams MC. The effect of sample preparation and storage on maternal triple-marker screening. Obstet Gynecol 1995;85:919–923.
   PubMed Web of Science ®Google Scholar
• Stone SJ, Henley R. The stability of blood samples for the measurement of the free beta subunit of chorionic gonadotrophin. Prenat Diagn 1995;15:95–96.
   PubMed Web of Science ®Google Scholar
• Kardana A, Cole LA. The stability of hCG and free beta-subunit in serum samples. Prenat Diagn 1997;17:141–147.
   PubMed Web of Science ®Google Scholar
• Massé J, Summers A, Cherian G, Forest J. Transportation of maternal serum specimens for screening for chromosomal aneuploidies: effect of seasonal variations, distance, and freezing on the stability of the biological markers. Clin Biochem 2000;33:273–277.
   PubMed Web of Science ®Google Scholar
• Sancken U, Bahner D. The effect of thermal instability of intact human chorionic gonadotropin (ihCG) on the application of its free beta-subunit (free beta hCG) as a serum marker in Down syndrome screening. Prenat Diagn 1995;15:731–738.
   PubMed Web of Science ®Google Scholar
• Cuckle HS, Jones RG. Posting maternal blood samples for free beta-human chorionic gonadotrophin testing. Prenat Diagn 1995;15:879–880.
   PubMed Web of Science ®Google Scholar
• Butler SA, Cole LA, Chard T, Iles RK. Dissociation of human chorionic gonadotropin into its free subunits is dependent on naturally occurring molecular structural variation, sample matrix and storage conditions. Ann Clin Biochem 1998;35 (Pt 6):754–760.
   PubMedGoogle Scholar
• Cowans NJ, Stamatopoulou A, Hellström J, Mäkelä MM, Spencer K. PAPP-A and free ss-hCG stability in first trimester serum using PerkinElmer AutoDELFIA and DELFIA Xpress systems. Prenat Diagn 2010;30:127–132.
   PubMed Web of Science ®Google Scholar
• Cole LA. Immunoassay of human chorionic gonadotropin, its free subunits, and metabolites. Clin Chem 1997;43:2233–2243.
   PubMed Web of Science ®Google Scholar
• Taylor J. Recommendations on the control and monitoring of storage and transportation temperatures of medicinal products. Pharm J 2001:267:128–131.
   Google Scholar
• Parenteral Drug Association. Technical Report No. 39. Cold chain guidance for medicinal products: maintaining the quality of temperature-sensitive products through the transportation environment. PDA J Pharm Sci Technol 2005 Sep-Oct: 59 (3 Suppl Tr39): 1–12.
   Google Scholar
• Health Canada. Guidelines for temperature control of drug products during storage and transportation (GUI – 0069). http://www.hc-sc.gc.ca/dhp-mps/compli-conform/gmp-bpf/docs/gui-0069-eng.php.
   Google Scholar
• Commission and Directive Commission Directive 2003/94/EC. Laying down the principles and guidelines of good manufacturing practice in respect of medicinal products for human use and investigational medicinal products for human use. OJ L 262, 14.10.2003.
   Google Scholar
• Elliott MA, Halbert GW. Maintaining the cold chain shipping environment for Phase I clinical trial distribution. Int J Pharm 2005;299:49–54.
   PubMedGoogle Scholar
• Muller F, Doche C, Ngo S, Faïna S, Charvin MA, Rebiffé M, Taguel V, Dingeon B. Stability of free beta-subunit in routine practice for trisomy 21 maternal serum screening. Prenat Diagn 1999;19:85–86.
   PubMed Web of Science ®Google Scholar